(Q33690247)

28 July 2017

1 reference

title

Hypericum perforatum extracts as potential antidepressants (English)

1 reference

28 July 2017

Hypericum perforatum

1 reference

Vitiello B

1

1 reference

28 July 2017

1 May 1999

1 reference

Journal of Pharmacy and Pharmacology

28 July 2017

1 reference

28 July 2017

51

1 reference

28 July 2017

5

1 reference

28 July 2017

513-517

1 reference

Oral bioavailability of hyperforin from hypericum extracts in rats and human volunteers

28 July 2017

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

Hypericin and pseudohypericin: pharmacokinetics and effects on photosensitivity in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

Antidepressant activity of hypericum perforatum and hyperforin: the neglected possibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

In vitro receptor binding and enzyme inhibition by Hypericum perforatum extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

St. John's wort in mild to moderate depression: the relevance of hyperforin for the clinical efficacy

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

St John's wort for depression--an overview and meta-analysis of randomised clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

Effects of hypericum extract (LI 160) in biochemical models of antidepressant activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

Hyperforin represents the neurotransmitter reuptake inhibiting constituent of hypericum extract.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

Biologically active and other chemical constituents of the herb of Hypericum perforatum L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

Solubilized hypericin and pseudohypericin from Hypericum perforatum exert antidepressant activity in the forced swimming test

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

The effect of hypericum extract on cardiac conduction as seen in the electrocardiogram compared to that of imipramine

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

Pharmacokinetics of hypericin and pseudohypericin after oral intake of the hypericum perforatum extract LI 160 in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

Efficacy and tolerability of St. John's wort extract LI 160 versus imipramine in patients with severe depressive episodes according to ICD-10

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

Pharmaceutical quality of hypericum extracts

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

LI 160, an extract of St. John's wort, versus amitriptyline in mildly to moderately depressed outpatients--a controlled 6-week clinical trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

Benefits and risks of the hypericum extract LI 160: drug monitoring study with 3250 patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1211%2F0022357991772781

Pharmaceutical Quality of Hypericum Extracts

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1177/089198879400701S18

Pharmacokinetics of Hypericin and Pseudohypericin after Oral Intake of the Hypericum Perforatum Extract LI 160 in Healthy Volunteers

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.1177/089198879400701S13

Identifiers

DOI

10.1211/0022357991772781

1 reference

28 July 2017

1 reference

PubMed ID

10411209